Cargando…

Analysis of pregnant women with critically severe COVID-19 in Korea from February 2020 and December 2021

OBJECTIVES: This study aimed to describe the characteristics and risk factors for severe disease in pregnant women infected with coronavirus disease 2019 (COVID-19) from the early days of the COVID-19 epidemic in Korea to the predominant period of the Delta variant. METHODS: A retrospective cohort s...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Ji Joo, Lee, Sang-Eun, Kim, Yeonjung, Park, Young-Joon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korea Disease Control and Prevention Agency 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10211450/
https://www.ncbi.nlm.nih.gov/pubmed/37183333
http://dx.doi.org/10.24171/j.phrp.2023.0025
_version_ 1785047278018363392
author Lee, Ji Joo
Lee, Sang-Eun
Kim, Yeonjung
Park, Young-Joon
author_facet Lee, Ji Joo
Lee, Sang-Eun
Kim, Yeonjung
Park, Young-Joon
author_sort Lee, Ji Joo
collection PubMed
description OBJECTIVES: This study aimed to describe the characteristics and risk factors for severe disease in pregnant women infected with coronavirus disease 2019 (COVID-19) from the early days of the COVID-19 epidemic in Korea to the predominant period of the Delta variant. METHODS: A retrospective cohort study was conducted among pregnant women diagnosed with COVID-19 between February 2020 and December 2021. Logistic regression analysis was performed to compare severe and mild cases after adjusting for pregnant women’s age, nationality, infection route, outbreak area, infection period, symptoms, underlying disease, smoking status, trimester, and COVID-19 vaccination status. RESULTS: In total, 2,233 pregnant women were diagnosed with COVID-19 by December 2021. Among these, 96.7% had mild symptoms, 3.3% had severe symptoms, and 0.04% died. The risk factors for severe disease in pregnant women with confirmed COVID-19 were being in the age group of 35 to 45 years, having hyperlipidemia, being in the second or third trimester of pregnancy at the time of COVID-19 diagnosis, being infected during the Delta-predominant period, and having a fever (≥38 °C) at diagnosis. Furthermore, 47.1% of patients in the mild group and 84.9% of patients in the severe group had 3 or more risk factors. CONCLUSION: Pregnant women with COVID-19 mainly experienced mild symptoms, but those with risk factors were at a higher risk of developing severe symptoms. Therefore, treatment and follow-up management should be thoroughly implemented.
format Online
Article
Text
id pubmed-10211450
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Korea Disease Control and Prevention Agency
record_format MEDLINE/PubMed
spelling pubmed-102114502023-05-26 Analysis of pregnant women with critically severe COVID-19 in Korea from February 2020 and December 2021 Lee, Ji Joo Lee, Sang-Eun Kim, Yeonjung Park, Young-Joon Osong Public Health Res Perspect Original Article OBJECTIVES: This study aimed to describe the characteristics and risk factors for severe disease in pregnant women infected with coronavirus disease 2019 (COVID-19) from the early days of the COVID-19 epidemic in Korea to the predominant period of the Delta variant. METHODS: A retrospective cohort study was conducted among pregnant women diagnosed with COVID-19 between February 2020 and December 2021. Logistic regression analysis was performed to compare severe and mild cases after adjusting for pregnant women’s age, nationality, infection route, outbreak area, infection period, symptoms, underlying disease, smoking status, trimester, and COVID-19 vaccination status. RESULTS: In total, 2,233 pregnant women were diagnosed with COVID-19 by December 2021. Among these, 96.7% had mild symptoms, 3.3% had severe symptoms, and 0.04% died. The risk factors for severe disease in pregnant women with confirmed COVID-19 were being in the age group of 35 to 45 years, having hyperlipidemia, being in the second or third trimester of pregnancy at the time of COVID-19 diagnosis, being infected during the Delta-predominant period, and having a fever (≥38 °C) at diagnosis. Furthermore, 47.1% of patients in the mild group and 84.9% of patients in the severe group had 3 or more risk factors. CONCLUSION: Pregnant women with COVID-19 mainly experienced mild symptoms, but those with risk factors were at a higher risk of developing severe symptoms. Therefore, treatment and follow-up management should be thoroughly implemented. Korea Disease Control and Prevention Agency 2023-04 2023-04-05 /pmc/articles/PMC10211450/ /pubmed/37183333 http://dx.doi.org/10.24171/j.phrp.2023.0025 Text en © 2023 Korea Disease Control and Prevention Agency. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ).
spellingShingle Original Article
Lee, Ji Joo
Lee, Sang-Eun
Kim, Yeonjung
Park, Young-Joon
Analysis of pregnant women with critically severe COVID-19 in Korea from February 2020 and December 2021
title Analysis of pregnant women with critically severe COVID-19 in Korea from February 2020 and December 2021
title_full Analysis of pregnant women with critically severe COVID-19 in Korea from February 2020 and December 2021
title_fullStr Analysis of pregnant women with critically severe COVID-19 in Korea from February 2020 and December 2021
title_full_unstemmed Analysis of pregnant women with critically severe COVID-19 in Korea from February 2020 and December 2021
title_short Analysis of pregnant women with critically severe COVID-19 in Korea from February 2020 and December 2021
title_sort analysis of pregnant women with critically severe covid-19 in korea from february 2020 and december 2021
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10211450/
https://www.ncbi.nlm.nih.gov/pubmed/37183333
http://dx.doi.org/10.24171/j.phrp.2023.0025
work_keys_str_mv AT leejijoo analysisofpregnantwomenwithcriticallyseverecovid19inkoreafromfebruary2020anddecember2021
AT leesangeun analysisofpregnantwomenwithcriticallyseverecovid19inkoreafromfebruary2020anddecember2021
AT kimyeonjung analysisofpregnantwomenwithcriticallyseverecovid19inkoreafromfebruary2020anddecember2021
AT parkyoungjoon analysisofpregnantwomenwithcriticallyseverecovid19inkoreafromfebruary2020anddecember2021